The Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates

被引：2114
|
作者：
Roughley, Stephen D. [1 ]
Jordan, Allan M. [2 ]
机构：
[1] Vernalis R&D Ltd, Cambridge CB21 6GB, England
[2] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Drug Discovery Unit, Manchester M20 4BX, Lancs, England
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2011年 / 54卷 / 10期
关键词：
CONVERTING ENZYME-2 INHIBITORS; D-3 RECEPTOR ANTAGONISTS; CROSS-COUPLING REACTIONS; PROPERTY BASED DESIGN; FACTOR XA INHIBITORS; PART; MORPHOLINE DERIVATIVES; BIOLOGICAL EVALUATION; REUPTAKE INHIBITORS; CHEMICAL-SYNTHESIS;
D O I：
10.1021/jm200187y
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：3451 / 3479
页数：29
相关论文
共 50 条
  • [41] Cardiovascular adverse drug reactions of ibrutinib, idelalisib, acalabrutinib and venetoclax used in chronic lymphocytic leukemia: Signal detection by disproportionality analysis from VigiBase®
    Pacheco-Paez, T.
    Conte, C.
    Montastruc, J. L.
    Despas, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 73 - 73
  • [42] Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions
    Pinheiro, Luis Correia
    Giezen, Thijs J.
    Wolff-Holz, Elena
    Weise, Martina
    Laslop, Andrea
    Hidalgo-Simon, Ana
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1311 - 1317
  • [43] Synthesis, modeling, bioactivity, docking, binding energy analysis of new effective piperazine derivatives as effective drug candidates for treatment of Parkinson's disease
    Shahab, Siyamak
    Kumar, Rakesh
    Sheikhi, Masoome
    Ihnatovich, Zanna
    Siniutsich, Julia
    Koroleva, Elena
    Filippovich, Liudmila
    Auhustsinovich, Anastasiya
    Makhakhei, Maryna
    Stati, Mikita
    Hui, Wang
    Khancheuski, Maksim
    Borzehandani, Mostafa Yousefzadeh
    ANALYTICAL CHEMISTRY LETTERS, 2024, 14 (05) : 638 - 653
  • [44] Incretin-based drugs and intestinal obstruction: analysis of the World Health Organization's adverse drug reactions database
    Gudin, B.
    Bres, V.
    Robin, P.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 53 - 53
  • [45] SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database
    Moumouni, Abdel Nasser Ado
    Robin, Perrine
    Hillaire-Buys, Dominique
    Faillie, Jean-Luc
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 (02) : 216 - 226
  • [46] Amitriptyline's anticholinergic adverse drug reactions-A systematic multiple-indication review and meta-analysis
    Brueckle, Maria-Sophie
    Thomas, Elizabeth T.
    Seide, Svenja Elisabeth
    Pilz, Maximilian
    Gonzalez-Gonzalez, Ana I.
    Dinh, Truc Sophia
    Gerlach, Ferdinand M.
    Harder, Sebastian
    Glasziou, Paul P.
    Muth, Christiane
    PLOS ONE, 2023, 18 (04):
  • [47] How do Adverse Drug Reactions Influence the Patient's Daily Life? Qualitative Analysis on Spontaneous Reports by Patients
    Rolfes, L.
    Haaksman, M.
    van Hunsel, F.
    van Puijenbroek, E.
    DRUG SAFETY, 2017, 40 (10) : 964 - 964
  • [48] Antibacterial Activity, Phytochemical Analysis of C. coggygria Leaf Extracts Against S. typhi, and Computational Studies to Screen Potential Drug Candidates
    Negi, Ankit
    Pant, Pooja
    Mathpal, Shalini
    Tewari, Disha
    Upadhyay, Santosh Kumar
    Chandra, Subhash
    Kumar, Rishendra
    INDIAN JOURNAL OF MICROBIOLOGY, 2024,
  • [49] Cardiovascular adverse drug reactions of Ibrutinib, Idelalisib, Acalabrutinib, and Venetoclax used in chronic lymphocytic leukemia: Systematic review -meta--analysis and Signal detection by disproportionality analysis from VigiBase®
    Pacheco-Paez, T.
    Conte, C.
    Rousseau, V.
    Chebane, L.
    Ysebaert, L.
    Levy, V.
    Montastruc, J. L.
    Despas, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 38 - 39
  • [50] SGLT-2 inhibitors and severe ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database
    Moumouni, A. N. Ado
    Robin, P.
    Bres, V.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 22 - 22
12345